Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Please share Science & Enterprise

NIH Opens $1M Maternal Health Diagnostics Challenge

Pregnant woman

National Institutes of Health began a competition for low-cost diagnostic technologies to improve maternal health, particularly in low-resource regions. . . . → Read More: NIH Opens $1M Maternal Health Diagnostics Challenge

Trial Shows Nasal Spray Relieves Migraine Pain

Nasal spray

Clinical trial results show a nasal spray treatment for acute migraine helps more users achieve relief from pain within two hours, and faster in some cases. . . . → Read More: Trial Shows Nasal Spray Relieves Migraine Pain

Oxford, GSK Partner on New Tech for Neuro Diseases

Brain circuits illustration

GlaxoSmithKline is funding a joint research center at University of Oxford to advance precision medical technologies, beginning with neurological disorders. . . . → Read More: Oxford, GSK Partner on New Tech for Neuro Diseases

$180M Venture Fund Backing Age-Related Disease Start-Ups

Hands of older person

A new venture capital fund aims to finance research entrepreneurs addressing root causes of age-related diseases with therapies and early diagnostics. . . . → Read More: $180M Venture Fund Backing Age-Related Disease Start-Ups

Covid-19 Antibody Cocktail Trial Request Filed

Human B-cell

A discoverer of synthetic antibodies is asking Food and Drug Administration for clearance to begin a clinical trial of a Covid-19 antibody cocktail therapy. . . . → Read More: Covid-19 Antibody Cocktail Trial Request Filed

Plant-Based Protein Biotech Raises $3M in Seed Funds

Vertical farm in Finland

A biotechnology start-up producing proteins with more sustainable and less costly plant-based processes is raising $3 million in its seed funding round. . . . → Read More: Plant-Based Protein Biotech Raises $3M in Seed Funds

Samsung, Biotech Partner on mRNA Vaccine Production

Vaccine vials

A developer of synthetic RNA products is partnering with Samsung Biologics to manufacture Covid-19 vaccines made with messenger RNA. . . . → Read More: Samsung, Biotech Partner on mRNA Vaccine Production

Regeneron Gains Cancer, Infectious Disease Immunotherapies

Regeneron lab

A biotechnology company is licensing five of its vaccines for cancer and infectious diseases to Regeneron Pharmaceuticals in a deal valued at nearly $1 billion. . . . → Read More: Regeneron Gains Cancer, Infectious Disease Immunotherapies

Trial Advances Test of Electronic Cancer Treatment

Inspecting lung X-rays

A clinical trial completed enrollment of lung cancer patients testing a device sending an electric field into their tumors to disrupt cancer cell proliferation. . . . → Read More: Trial Advances Test of Electronic Cancer Treatment

Cell Therapy Start-Up Raises $6M in Seed Funds

Stem cells

A new company providing clinical development and commercialization for emerging cell therapies began operations and raised $6 million in seed funding. . . . → Read More: Cell Therapy Start-Up Raises $6M in Seed Funds